August 26, 2021 – BD (Becton, Dickinson and Company) (Franklin Lakes, NJ) announced the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the BD Veritor At-Home COVID-19 Test, which does not require a prescription, a laboratory, or a long wait for results.
According to BD, this is the first at-home COVID-19 rapid antigen test to use computer vision technology in a smartphone to interpret and provide a digital display of testing results.
The BD Veritor At-Home COVID-19 Test is a lateral flow antigen self-test is designed to be easily performed at home by people 14 years of age or older, using Scanwell Health’s app to provide results in 15 minutes.
The test can also be used for children as young as two years old with samples collected by an adult.
The app is available on iOS and Android and provides step-by-step instructions on how to collect and transfer the nasal swab sample to the test stick. The mobile device’s camera is then used to capture, analyze and interpret the results.
The test will initially be made available to businesses, schools and governments looking to provide a self-testing option for employees or students. The BD Veritor At-Home COVID-19 Test will use a nasal swab and a mobile app from Scanwell Health that yields test results in 15 minutes.